RG1678 drug
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| RG1678 | protective_against | negative symptoms | 0.05 | 1 |
| RG1678 | protective_against | schizophrenia | — | 1 |
Mentioned in (2)
Papers in which this entity is mentioned.
- Hypomania after augmenting venlafaxine and olanzapine with sarcosine in a patient with schizophrenia: a case study. (2015)
- Glutamatergic transmission in schizophrenia: from basic research to clinical practice. (2012)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| rg1678 | drug | 2 | 2 |
| glycine transport inhibitor rg1678 | drug | — | — |